Crohn’s & Colitis Foundation Inc-製薬・医療分野:企業M&A・提携分析

【英語タイトル】Crohn's & Colitis Foundation Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

GlobalDataが出版した調査資料(DATA8014118)・商品コード:DATA8014118
・発行会社(調査会社):GlobalData
・発行日:2017年11月22日
・ページ数:20
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥28,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥56,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥84,750見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000を加算
※納期:即日~2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Summary
Crohn’s & Colitis Foundation Inc (CCF) is a non-profit organization which focuses on providing treatments for crohn’s disease and ulcerative colitis. The organization funds studies at medical institutions, nurture investigators, and finance underdeveloped areas of research. CCF’s partners include European Federation of Crohn’s and Ulcerative Colitis Associations, International Organization of Inflammatory Bowel Disease (IOIBD) and International Ostomy Association. It supports ongoing research initiatives and clinical studies to encourage cooperation among investigators, research centers, and other resources.The organization works in collaboration with healthcare providers and caregivers to deliver education, awareness and support services through patient-centric education and advocacy programs to patients suffering from inflammatory bowel diseases. CCF is headquartered in New York, the US.

Crohn’s & Colitis Foundation Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Crohn’s & Colitis Foundation Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Crohn’s & Colitis Foundation Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Crohn’s & Colitis Foundation Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Crohn’s & Colitis Foundation Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Crohn’s & Colitis Foundation Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Crohn’s & Colitis Foundation Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
CCFA Enters into Research Agreement with Penn Med and Nestle Health Science 10
Crohn’s & Colitis Foundation of America and Pfizer Enter into Agreement for Inflammatory Bowel Disease 11
Merger 12
Broad Foundations To Merge With Crohn’s & Colitis Foundation 12
Crohn’s & Colitis Foundation Inc – Key Employees 13
Crohn’s & Colitis Foundation Inc – Locations And Subsidiaries 14
Head Office 14
Recent Developments 15
Government and Public Interest 15
Oct 30, 2017: Crohn’s & Colitis Foundation Receives $5 Million to Fund Innovative Translational and Clinical IBD Research 15
Sep 11, 2017: Scientists Construct First Predictive Model of Inflammatory Bowel Disease 16
Mar 24, 2016: First-Ever National Study of Dietary Interventions to Treat Crohn’s Disease Receives Funding 17
Mar 08, 2016: Immune Response Research Critical To Understanding Pathology Of Crohn’s Disease & Ulcerative Colitis 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Crohn's & Colitis Foundation Inc, Pharmaceuticals & Healthcare, Key Facts 2
Crohn's & Colitis Foundation Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Crohn's & Colitis Foundation Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Crohn's & Colitis Foundation Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Crohn's & Colitis Foundation Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Crohn's & Colitis Foundation Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
CCFA Enters into Research Agreement with Penn Med and Nestle Health Science 10
Crohn’s & Colitis Foundation of America and Pfizer Enter into Agreement for Inflammatory Bowel Disease 11
Broad Foundations To Merge With Crohn's & Colitis Foundation 12
Crohn's & Colitis Foundation Inc, Key Employees 13

★調査レポート[Crohn’s & Colitis Foundation Inc-製薬・医療分野:企業M&A・提携分析] (コード:DATA8014118)販売に関する免責事項を必ずご確認ください。
★調査レポート[Crohn’s & Colitis Foundation Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆